Cargando…

Characterization of health concerns in people with neurofibromatosis type 1

BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleming, Jane, Morgan, Oliver, Wong, Claire, Schlub, Timothy E., Berman, Yemima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834143/
https://www.ncbi.nlm.nih.gov/pubmed/36444392
http://dx.doi.org/10.1002/mgg3.2077
_version_ 1784868396217663488
author Fleming, Jane
Morgan, Oliver
Wong, Claire
Schlub, Timothy E.
Berman, Yemima
author_facet Fleming, Jane
Morgan, Oliver
Wong, Claire
Schlub, Timothy E.
Berman, Yemima
author_sort Fleming, Jane
collection PubMed
description BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a population cohort. METHODS: An online survey was completed by 68 adults and 32 parents of children with NF1, and 60 controls. The survey included the Skindex‐29 QOL scale, 5D‐itch scale, and additional health questions. RESULTS: Frequency of itch was high in children (50%) and adults (69%), with most expressing interest in treatment for itch. The presence of itch and increased visibility of NF1 were predictors of poorer QoL. Many adults (53%) and parents (44%) desired access to treatment to improve cosmetic appearance. Muscle weakness/tiredness was also prevalent amongst (60–70%) adults and children with NF1. Two‐thirds of adults with NF1 reported limited awareness of NF1 services and poor knowledge of surveillance, particularly breast screening in young women. CONCLUSION: This study highlights the impact of NF1‐related itch and visibility in adults and children with a need for cosmetic and itch treatment. The findings emphasize a need for strategies to promote awareness, and access to management and treatment of NF1 in adults.
format Online
Article
Text
id pubmed-9834143
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98341432023-01-13 Characterization of health concerns in people with neurofibromatosis type 1 Fleming, Jane Morgan, Oliver Wong, Claire Schlub, Timothy E. Berman, Yemima Mol Genet Genomic Med Original Articles BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a population cohort. METHODS: An online survey was completed by 68 adults and 32 parents of children with NF1, and 60 controls. The survey included the Skindex‐29 QOL scale, 5D‐itch scale, and additional health questions. RESULTS: Frequency of itch was high in children (50%) and adults (69%), with most expressing interest in treatment for itch. The presence of itch and increased visibility of NF1 were predictors of poorer QoL. Many adults (53%) and parents (44%) desired access to treatment to improve cosmetic appearance. Muscle weakness/tiredness was also prevalent amongst (60–70%) adults and children with NF1. Two‐thirds of adults with NF1 reported limited awareness of NF1 services and poor knowledge of surveillance, particularly breast screening in young women. CONCLUSION: This study highlights the impact of NF1‐related itch and visibility in adults and children with a need for cosmetic and itch treatment. The findings emphasize a need for strategies to promote awareness, and access to management and treatment of NF1 in adults. John Wiley and Sons Inc. 2022-11-28 /pmc/articles/PMC9834143/ /pubmed/36444392 http://dx.doi.org/10.1002/mgg3.2077 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Fleming, Jane
Morgan, Oliver
Wong, Claire
Schlub, Timothy E.
Berman, Yemima
Characterization of health concerns in people with neurofibromatosis type 1
title Characterization of health concerns in people with neurofibromatosis type 1
title_full Characterization of health concerns in people with neurofibromatosis type 1
title_fullStr Characterization of health concerns in people with neurofibromatosis type 1
title_full_unstemmed Characterization of health concerns in people with neurofibromatosis type 1
title_short Characterization of health concerns in people with neurofibromatosis type 1
title_sort characterization of health concerns in people with neurofibromatosis type 1
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834143/
https://www.ncbi.nlm.nih.gov/pubmed/36444392
http://dx.doi.org/10.1002/mgg3.2077
work_keys_str_mv AT flemingjane characterizationofhealthconcernsinpeoplewithneurofibromatosistype1
AT morganoliver characterizationofhealthconcernsinpeoplewithneurofibromatosistype1
AT wongclaire characterizationofhealthconcernsinpeoplewithneurofibromatosistype1
AT schlubtimothye characterizationofhealthconcernsinpeoplewithneurofibromatosistype1
AT bermanyemima characterizationofhealthconcernsinpeoplewithneurofibromatosistype1